Can antiviral drugs address the treatment challenges of severe fever with thrombocytopenia syndrome? - a systematic meta-analysis

严重发热伴血小板减少综合征 医学 法维皮拉维 利巴韦林 荟萃分析 科克伦图书馆 内科学 抗病毒药物 病毒载量 药品 重症监护医学 疾病 传染病(医学专业) 药理学 免疫学 病毒 2019年冠状病毒病(COVID-19) 丙型肝炎病毒
作者
Lumeng Shen,Mingfang Han,Jingjing Lou,Wenya Shen,Shibo Li
出处
期刊:Journal of Infection in Developing Countries [Open Learning on Enteric Pathogens]
卷期号:18 (11): 1645-1652 被引量:1
标识
DOI:10.3855/jidc.19032
摘要

Background: Severe Fever with Thrombocytopenia Syndrome (SFTS) is an emerging infectious disease with high mortality and severity rates. However, there is no clear treatment plan, specific effective antiviral drugs, or effective vaccine for SFTS. Recent studies have shown that the therapeutic effect of Ribavirin and other commonly used antiviral drugs such as Favipiravir (T-705), on SFTS is still controversial. This meta-analysis was conducted to evaluate the therapeutic efficacy of antiviral drugs on SFTS. Methods: Relevant studies were searched from Cochrane Library, Web of Science, Embase. and PubMed from inception to June 30, 2022, and updated to 2023. The study screening, data extraction, and quality assessment were conducted by re-searchers independently. A counterpart assessment tool was used to assess methodological quality, and the Stata15 software was employed to perform meta-analysis. Results: The meta-analysis included 8 studies consisting of 4692 patients. The results showed no significant difference in the mortality rate of SFTS patients between the antiviral drug group and the control group (HR: 0.85, 95% CI: 0.46–1.59, p = 0.618). Antiviral drugs had no noticeable effect on this disease (RR: 0.93, 95% CI: 0.58–1.48, p = 0.747). Conclusions: At present, antiviral drugs (Ribavirin and Favipiravir) used routinely in clinics show no positive effect on the treatment of SFTS yet and fail to reduce the mortality rate. On the other hand, clinical studies specifically evaluating viral load found that antiviral drugs were effective in the treatment of SFTS patients with low viral load, but the efficacy was not statistically significant.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小蘑菇的应助被红莲墨生采纳,获得10
刚刚
Sepnine9完成签到,获得积分10
1秒前
1秒前
汉堡包的应助被虚心的梦容采纳,获得10
1秒前
Maestro_S的应助被yang采纳,获得10
2秒前
无花果的应助被Mp4采纳,获得10
4秒前
白betty完成签到,获得积分10
4秒前
洛楠完成签到,获得积分10
5秒前
黑米粥发布了新的文献求助200
6秒前
7秒前
bingo发布了新的文献求助10
8秒前
Chara完成签到 ,获得积分10
8秒前
rrl完成签到 ,获得积分10
8秒前
李爱国的应助被vc采纳,获得10
9秒前
9秒前
molihuakai的应助被jenny采纳,获得10
9秒前
10秒前
11秒前
红莲墨生发布了新的文献求助10
12秒前
李健的小迷弟的应助被Cyx采纳,获得10
12秒前
13秒前
Chara关注了科研通微信公众号
13秒前
13秒前
长青发布了新的文献求助10
13秒前
13秒前
14秒前
希望天下0贩的0的应助被w7采纳,获得10
14秒前
希望天下0贩的0的应助被Bai采纳,获得10
14秒前
Colin发布了新的文献求助10
15秒前
15秒前
15秒前
15秒前
Sepnine9关注了科研通微信公众号
15秒前
Mp4发布了新的文献求助10
16秒前
16秒前
记忆力超人完成签到,获得积分10
19秒前
巫衣絮完成签到,获得积分10
20秒前
20秒前
20秒前
搞怪建辉发布了新的文献求助30
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184336
求助须知:如何正确求助?哪些是违规求助? 9573358
关于积分的说明 21830993
捐赠科研通 7781367
什么是DOI,文献DOI怎么找? 3434307
关于科研通互助平台的介绍 2558401
邀请新用户注册赠送积分活动 2480846